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ABSTRACT

Entamoeba histolytica is a parasitic human protozoan that infects 500,000,000 people
worldwide annually. In the course of the parasite’s life cycle, motile trophozoites breach
the colonic mucosa, invade through the epithelial layer and extracellular matrix (ECM)
and occasionally disseminate through portal blood vessels to distant organs. Membrane
rafts are small heterogeneous, highly dynamic, sterol- and sphingolipid- enriched
domains whose functional significance entails compartmentalization of cellular processes
and regulation of cellular signaling. Recent studies reveal the physiological role of
membrane rafts in adhesion to host epithelium in E. histolytica. In the current study we
examined the role of lipid rafts in adhesion of trophozoites to host ECM components,
collagen and fibronectin. A high throughput fluorescence based assay was developed to
assess parasitic adhesion to commercial collagen type I- and fibronectin-coated microtiter
plates. Disruption of membrane rafts by treatment with a cholesterol extracting agent,
methyl-beta-cyclodextrin (MβCD), resulted in inhibition of adhesion to ECM.
Replenishment of cholesterol by treatment with a lipoprotein-cholesterol concentrate
(LCC) restored adhesion. Confocal microscopy, using fluorescent lipid analogs, revealed
enrichment of lipids at the parasite-ECM interface. The galactose inhibitable Gal/GalNAc
lectin is a glycoprotein on E. histolytica that is a known resident of lipid rafts and
mediates adhesion to host cells. Adhesion to collagen was observed to decline in
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the presence of galactose, suggesting a role for the Gal/GalNAc lectin as a putative
receptor mediating adhesion to collagen. On the other hand, adhesion to fibronectin was
not impaired by galactose, suggesting that the Gal/GalNAc lectin is not involved in
adhesion of E. histolytica to fibronectin. This study has offered new insight into the
molecular mechanisms of adhesion, which is important to the pathogenesis of amoebiasis.
Such insight may lead to the development of innovative therapeutic modalities and
vaccines.
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CHAPTER 1
LITERATURE REVIEW
I. Introduction
Epidemiological significance
Entamoeba histolytica is a human intestinal pathogen that causes approximately 100,000
deaths worldwide annually [1]. Interestingly, the origin of its name (“histolytica”) bears
reference to its “tissue destroying ability” [reviewed in 2]. In terms of mortality attributed
to protozoan parasites, E. histolytica ranks second worldwide, next only to malaria, thus
emphasizing the epidemiological significance of this infectious agent [1]. Previously,
based on results of microscopic stool analysis, E. histolytica was believed to infect 500
million people worldwide. However, advances in diagnostic techniques have revealed the
existence of two morphologically identical but antigenically distinct strains, Entamoeba
histolytica and Entamoeba dispar. These strains bear biochemical and genetic differences,
and can be antigenically distinguished using PCR-based commercially available kits. It is
now believed that E. histolytica is primarily a pathogenic strain, whereas E. dispar is a
non-pathogenic commensal [reviewed in 3].

E. histolytica is transmitted through the fecal-oral route, and there is higher disease
prevalence in areas with inadequate sanitation and environmental hygiene. In
industrialized countries travelers, immigrants, institutionalize populations and homo-
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sexual men constitute the high risk group for contracting the disease [4]. E. histolytica
has emerged as an important opportunistic pathogen in chronically immunosuppressed
patients, such as people suffering from HIV-AIDS. Such patients are also at a higher risk
of developing invasive amoebiasis, in comparison to immune-competent subjects [5].

Given the ease of transmission by the fecal-oral route and the morbidity associated with
amoebic dysentery, it is no surprise that E. histolytica has been classified as a category B
bioterrorism agent by the National Institutes of Health. That the parasite can be
manipulated genetically and that amoebiasis is difficult to diagnose supports its
classification as an agent of biowarfare. Therefore, there is elevated priority to understand
pathogenesis; such insight may lead to new methods of disease prevention, detection and
treatment.

Life cycle and pathogenesis
E. histolytica is a unicellular eukaryotic protozoon that is transmitted by the fecal-oral
route. It exhibits a simple life cycle consisting of two stages, namely the cyst and the
trophozoite. E. histolytica cysts are round, quadrinucleated and measure 10-15 µm in
diameter. Ingestion of infective cysts occurs via contaminated food and water. So far,
humans and a few primates are the only known natural hosts for E. histolytica. The cysts
are resistant to the acidic environment of the gastric lumen, and excystation occurs in the
terminal ileum and colon. After excystation, both the cytoplasm and nuclei divide to
produce eight metacystic, motile trophozoites, which measure 10-50 µm in diameter. In
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most cases, trophozoites re-encyst within the lumen of the colon and the cysts are passed
in stool, thus completing the life cycle of the parasite [6].

In some cases, the colonic lumen may become colonized by trophozoites, a process that
involves interaction of trophozoites with the protective layer of mucin that lines the
intestinal epithelium and forms the body’s first line of defense [7]. This interaction
involves adhesion, degradation and subsequent invasion of mucin, which brings the
parasite in contact with submucosal epithelium. During such invasion, trophozoites are
driven by nourishment derived from intestinal bacteria and food particulates [6].
Amoebapore, a polypeptide that disrupts bacterial and host cell membranes, and cysteine
proteases, a group of enzymes that degrade host cells and ECM, are secreted
extracellularly by trophozoites at this stage and are important virulence factors that
regulate invasion [2].

Destruction of intestinal epithelium and degradation of extracellular matrix (ECM) that
surrounds epithelial cells results in formation of flask-shaped amoebic ulcers [8]. These
pathological changes are manifested in the form of watery diarrhea, dysentery, tenesmus
and colitic pain in the abdomen. Highly invasive trophozoites encounter the vascular
tissue in the vicinity of the ulcers, and may disseminate through the blood stream to other
organs, such as liver, lungs and brain [2]. Patients of amoebic liver abscess present with
pain in abdomen, pyrexia, weight loss and fatigue. In rare instances, other complications
may include cutaneous amoebic ulcers, subphrenic abscess, pericarditis and peritonitis [9].
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Currently, medical management with nitroimidazoles is the first line of treatment of
amoebiasis. However, the rate of luminal eradication of cysts with this drug is not very
high. There has also been emergence of drug resistance that has further compounded the
problem of disease eradication [reviewed in 2]. A comprehensive understanding of the
molecular mechanisms of pathogenesis can thus contribute significantly to the
development of potential drug targets and novel approaches to vaccine development.

II. Physiological role of adhesion
Adhesion is a critical step in the pathogenesis of amoebiasis. E. histolytica adhere to
bacteria in the colonic lumen, a process that provides nourishment and sustains the
parasite [6]. Association of Escherichia coli with E. histolytica trophozoites in vitro has
been shown to enhance host cell destruction [10]. Additionally, studies indicate that
exposure to E. coli induces transcription of various genes such as protein kinase, ABC
transporter, Rab family GTPases and hsp 90, all of which may enhance the phagocytic
capacity of E. histolytica [11]. Therefore, adhesion to bacterial flora of the intestine may
also modulate parasitic virulence. Subsequent stages of colonization and invasion of the
human body involve adhesion of the parasite to mucin, intestinal epithelium and ECM
components.

Mucins are glycoproteins possessing a significant number of O-linked glycan
modifications. This mucous gel layer is the body’s first line of defense against infection.
Colonization in the intestine is initiated by adherence of trophozoites to host
glycoconjugates via specific, yet poorly understood, receptors [12]. Evidence suggests
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that the association between E. histolytica trophozoites and colonic mucins is mediated
by a galactose and N-acetyl-D-galactosamine inhibitable lectin on the amoebic surface,
known as the Gal/GalNAc lectin [7]. It has been shown that interaction with mucins may
trigger signaling pathways in E. histolytica, especially those that regulate encystation [13].
Evidence that the Gal/GalNAc lectin is involved in adhesion to mucin includes the
observation that galactose and N-acetyl-D-galactosamine residues of mucins specifically
inhibit binding of the amebic 170 kDa heavy subunit of the Gal/GalNAc lectin to target
cells [7]. Additionally, there is also evidence that the interaction of trophozoites with
mucins decrease cytolysis of host epithelium in vitro [7].

Once the mucin barrier is breached, E. histolytica trophozoites can bind to host cells. It
has been previously reported that E. histolytica kills target cells in a contact-dependant
fashion [14]. The host target cells studied include a number of cell types of epithelial
origin as well as erythrocytes that are encountered during host tissue destruction. The
latter, which may also be taken up by phagocytosis, may serve as a source of nourishment
for invasive trophozoites [15]. These findings indicate that adherence of trophozoites to
target cells is an important step involved in disease pathogenesis. Subsequent to cytolysis
of epithelial cells, invading trophozoites encounter the ECM. Collagen and fibronectin
are important ECM components that have been studied in the context of E. histolyticahost interaction [16, 17].

Several lines of evidence suggest that interaction of E. histolytica with ECM components
in the invasive stage of amoebiasis may be likened to focal adhesions of higher
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eukaryotes [16, 17]. Focal adhesions are complex, dynamic supramolecular aggregates
containing integrins, which are α/β heterodimeric proteins occurring at the sites of
cellular attachment to ECM [18]. A more detailed discussion of proteins of the integrin
family is provided below. In mammalian cells, focal adhesions are characterized by
interaction of integrins with cytoplasmic proteins and cytoskeletal elements, thus acting
as the mechanical link between ECM and the cytoplasm [reviewed in 18]. Interestingly,
integrins can also propagate ECM-induced signaling. It is believed that the interaction of
E. histolytica with host ECM components can alter signal transduction pathways and
enhance parasitic virulence [16, 19, 20]. For example, exposure of E. histolytica
trophozoites to collagen induces actin accumulation in adhesion plates and
phosphorylation of tyrosine residues on the E. histolytica homolog of pp125FAK [17, 21].
In mammalian cells, adhesion-induced focal adhesion kinase (FAK) activation has been
described as a hallmark of integrin-mediated signaling. pp125FAK is a non receptor
cytosolic protein that localizes to focal adhesion plaques and is a substrate for tyrosine
kinase phosphorylation [21]. Exposure of E. histolytica to collagen also stimulates
pp125FAK association with paxillin and Src (pp60src), which may result in increased DNA
binding of the transcription factor AP-1 [22]. Collagen also induces phosphorylation of
p42MAPK, which may propagate a phosphorylation-based signal from the plasma
membrane to the nucleus [21]. In addition, exposure of trophozoites to collagen has been
shown to increase DNA binding of other E. histolytica transcription factors such as
STAT1 and STAT3 [19]. This, in turn, may regulate changes in gene expression. In
support of this, collagen exposure results in increased expression of amoebapore and a
cysteine protease, two proteins that are secreted by E. histolytica [20].
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Thus, the

upregulation of their expression upon exposure of trophozoites to collagen emphasizes
the significance of trophozoite-ECM interactions in host invasion.

Likewise, binding of E. histolytica trophozoites to fibronectin induces phosphorylation of
pp125FAK , association of an integrin like receptor with paxillin, and activation of protein
kinase A (PKA) [23, 24], a protein involved in G-protein coupled receptor signaling.
Additionally, exposure to fibronectin induces reorganization of actin and its redistribution
to the sites of adhesion [16, 25]. It is thus surmised that the interaction of E. histolytica
trophozoites with ligands on target cell surface, and on extracellular host components,
may trigger signaling pathways within the trophozoites, in addition to intracellular
cytoskeletal rearrangements. Thus, a better understanding of this interaction at the
molecular level can provide further insight into determinants of invasion and disease
pathogenesis.

III. Molecular components involved in adhesion
Several adhesion molecules of E. histolytica that are involved in amoebic adhesion to
host components have been described [reviewed in 2]. These include a cysteine protease
(EhCPADH112), L220, serine-rich E. histolytica protein (SREHP), the Gal/ GalNAc
lectin, and several integrin-like receptors.

The EhCPADH112 is a transmembrane protein that localizes to the cysteine proteaseadhesin complex in the plasma membrane and phagosomes of trophozoites. Though the
ligand specificity of this adhesion molecule is still under investigation, in vitro
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experiments indicate that adhesion to host cells is inhibited in the presence of antibodies
to this protein, thereby establishing its role in the process of adhesion [26, 27]. The L220
is a 220 kDa lectin-like protein on the plasma membrane involved in binding to host cells.
The SREHP is another surface protein implicated in adhesion to host components. While
antibodies to SREHP as well as L220 are known to inhibit adhesion to host cells, their
exact ligand binding properties are still unclear [28-30]. The adhesion proteins that are
most relevant to this study are the Gal/GalNAc lectin, and integrin-like proteins, both of
which are described subsequently.

Gal/GalNAc lectin: trophozoite interaction with host cell and mucin
The significance of adhesion in the pathogenesis of amoebiasis sparked interest in the
scientific community as far back as the early 1980s. Studies examining the effects of
carbohydrates on adhesion of E. histolytica to Chinese hamster ovary (CHO) cells and
human erythrocytes (RBC) revealed that GalNAc inhibits adhesion to host cells by
binding a receptor on the amoebic surface [14]. It was also revealed from this study that
adherence is required prior to target cell lysis, the latter being an event which is
concomitantly inhibited in the presence of GalNAc. Thus, it was evident that E.
histolytica trophozoites adhere to host cell surface via a specific amoebic receptor that
possesses affinity for GalNAc. In 1985, the first report describing a soluble GalNAcinhibitable lectin in E. histolytica emerged. A 43-67 kDa Gal/GalNAc lectin, as it was
named,

was

found

to

agglutinate

host

polymorphonuclear neutrophils [31].
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Subsequently, the subunit structure of Gal/GalNAc lectin was discovered. The
Gal/GalNAc lectin is composed of a 170 kDa transmembrane heavy chain subunit (Hgl)
linked via a disulphide bond to a 31-35 kDa glycosylphosphatidylinositol (GPI)-anchored
light subunit (Lgl). These subunits are non-covalently associated with a 150 kDa
intermediate subunit (Igl) [reviewed in 2]. The Hgl subunit is comprised of a large
cysteine-rich extracellular domain, a single transmembrane domain, and a 41 amino acid
cytoplasmic domain [32]. Hgl exhibits some homology in its C terminus with β2 and β7
mammalian integrins [33, 34]. The Lgl and Igl subunits lack cytoplasmic domains [35].

That the Gal/GalNAc lectin is a cell surface protein has been confirmed by indirect
immunofluorescence [36]. It is believed to be part of a signal-associated complex [37],
and proteomic studies have revealed the association of its subunits with cytoskeletal and
signaling proteins [35]. Monoclonal antibodies specific for the 170 kDa receptor have
been demonstrated to inhibit binding of trophozoites to mucin [7]. Additionally,
incubation of trophozoites onto host epithelial cells, in the presence of antibodies directed
against the heavy subunit (Hgl) has shown nearly 100% inhibition of adhesion,
implicating Hgl as a primary contributor involved in adhesion to host cells [38].
Therefore, it is likely that the Hgl is involved in adhesion to multiple host components at
various stages of invasion. Characterization of binding affinities of glycoconjugates with
terminal Gal and Gal/GalNAc residues has indicated that carbohydrate ligands with
multiple Gal/GalNAc residues (i.e., multivalent) are the most potent inhibitors of
trophozoite adhesion [12].
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Interestingly, the Gal/GalNAc lectin is strongly immunogenic, and has been shown to
elicit an anti-lectin IgA response in rats. Moreover, isolated IgA purified from immunized
animals possesses inhibitory activity against adhesion in vitro [39]. More recently,
clinical trials in Bangladesh, an amoebiasis-endemic country, have indicated that a
mucosal IgA anti-lectin antibody response in humans confers immunity against E.
histolytica colonization [40]. Thus, the Gal/GalNAc is now recognized as a prime target
for subunit vaccine development [41].

Integrin-like receptors: trophozoite interaction with ECM
Integrins are transmembrane adhesion proteins comprised of α/β heterodimers, which link
the ECM components to cell cytoskeleton [42]. When cells come in contact with
extracellular substrates, integrin molecules, that are engaged by ECM ligands, induce
various intracellular signaling pathways through outside to inside signaling. Concurrently,
focal adhesions are formed at the cell-ECM interface that connect ECM, integrins,
cytoskeletal adaptor proteins (talin, vinculin, actin), as well as signaling proteins,
resulting in inside to outside signaling [42]. The ligand specificity during cell-ECM
binding is determined by α/β association of integrin heterodimers [18]. So far, in E.
histolytica, only proteins with homology to β subunits of integrins have been isolated [24,
43].

Interaction of trophozoites with fibronectin has been shown to induce formation of focal
adhesion-like structures, which recruit polymerized actin [16, 25].This interaction is
postulated to be mediated by a fibronectin receptor (β1EhFNR) which, upon adhesion to
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fibronectin, assembles a supramolecular signaling complex that induces tyrosine
phosphorylation. It has been shown that this multimolecular complex is composed of the
β1EhFNR, FAK, paxillin and vinculin [24]. Characterization of the β1EhFNR has
revealed that it is a 140 kDa protein localized to the cell surface [44]. This receptor is
recognized by a human anti-β1 integrin 3C10 monoclonal antibody in immunoblot assays
[45]. This antibody has been found to significantly inhibit adhesion of trophozoites to
fibronectin and collagen, and partially to another ECM component, laminin, thereby
implicating a role for β1EhFNR in adhesion to each of these extracellular substrates. In
further support of this, earlier studies have shown that a β-integrin-like molecule
colocalizes with actin as well as collagen in trophozoites exposed to collagen [17]. A
recent study demonstrated mobilization of the receptor from internal vesicles to the
plasma membrane on stimulation with fibronectin [45]. Perhaps the most interesting
discovery in this regard has been that the amino acid sequence for the β1EhFNR shares
99% and 96% homology with the genes encoding for Igl2 and Igl1 (intermediate subunit
of the Gal/GalNAc lectin), respectively, thus providing a link between the two widely
studied amoebic adhesion receptors for host cells and ECM [45].

A recent study has provided evidence for a second, distinct receptor that shares a
homologous epitope with neutrophilic β2 integrin [43]. This receptor is distinct from the
Gal/GalNAc lectin, and anti-β2 integrin antibody has been found to inhibit adhesion of E.
histolytica trophozoites to TNF-α-activated ICAM-expressing cells [43]. ICAM is the
traditional legend for β2 integrins. This discovery is exciting as it has opened avenues for
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future research into the potential role of this molecule in adhesion, as well, as
identification of extracellular ligands for this receptor.

Purification of membrane proteins that interact with collagen at 37oC in E. histolytica has
revealed the existence of seven plasma membrane proteins ranging from 51 kDa to 220
kDa. These proteins are hydrophilic, and thus putatively reside on the extracellular
surface of the pathogen [46]. Further characterization of interaction of these proteins with
collagen may identify a putative receptor for collagen.

Lipid rafts and their role in adhesion
Membrane rafts are defined as highly dynamic sterol- and sphingolipid-enriched domains
that compartmentalize cellular processes [47]. Rafts are 10-200 nm platforms that
spatially and temporally regulate physiological events. They are resistant to non-ionic
detergent lysis at 4oC and hence referred to as detergent-resistant membranes (DRMs).
Lipid rafts have also been shown to possess transmembrane proteins recognized for
trafficking. Some proteins constitutively reside in rafts, such as the GPI-anchored
proteins, while other proteins may accumulate within rafts upon oligomerization or
engagement with ligands [48]. A constitutive raft protein, the monosialoganglioside and
glycosphingolipid, GM1, has been frequently utilized as a raft marker [49].

The biological role of lipid rafts has been the subject of numerous studies, which have
implicated them in cellular processes like membrane sorting and trafficking, signal
transduction and cell polarization [50]. There is a mounting body of evidence suggesting
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the involvement of lipid rafts in multiple stages of host-pathogen interactions, including
adhesion, internalization, phagosome maturation and lysosomal fusion, intracellular
signaling, apoptotic induction and cytokine secretion [51]. Recent evidence suggests that
lipid rafts in the plasma membrane of E. histolytica play an important role in endocytosis,
secretion and adhesion of the parasite to host cells [52]. The existence and physiological
relevance of these rafts in E. histolytica has been shown through a variety of methods.
For

example,

fluorescence

microscopy

using

a

fluorescent

lipid

analog,

dialkyindocarbocyanine (DiIC16), has revealed raft enrichment in plasma membranes as
well as intracellular structures. Moreover, depletion of cholesterol by treatment of cells
with methyl-beta-cyclo-dextrin (MβCD), a reagent that encapsulates cholesterol in its
hydrophobic core, has been found to abolish DiIC16 staining in the plasma membrane.
Raft disruption using MβCD has also been found to significantly inhibit adhesion of E.
histolytica to host epithelial cells. Finally, using sucrose density centrifugation, rafts have
been purified from E. histolytica membranes and have been found to be enriched with the
Gal/GalNAc lectin [52].

In higher eukaryotes, lipid rafts serve as signaling platforms in which integrins, as well as
other adhesion/signaling molecules, may reside or accumulate in a signal-dependent
fashion [53, 54]. Various cell surface receptors involved in signal transduction have been
reported to associate with lipid rafts, including integrins [55]. Previous studies indicate
that the amoebic adhesion molecule Gal/GalNAc lectin is localized to rafts, thereby
supporting the role of membrane microdomains in adhesion of E. histolytica [52]. It has
been established that lipid rafts also play an important role in adhesion of neural
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precursor cells to extracellular matrix [56]. Furthermore, Huang et al. [57] recently
demonstrated that disruption of lipid rafts in human cancer cell lines inhibits cellular
adhesion to fibronectin, collagen and laminin, thereby affecting a crucial step in tumor
invasion and metastasis. However, so far, it is unclear whether lipid rafts are involved in
adhesion of E. histolytica to host ECM components and mucin.

Cholesterol has been described as the dynamic glue that maintains raft assembly, as it has
a higher affinity for raft sphingolipids than for unsaturated phospholipids [50]. Being a
major constituent of eukaryotic membranes, it is conceivable that the membrane
cholesterol content might impact lipid raft assembly and function. Previous research has
indicated that acute depletion of cholesterol content of macrophages significantly
decreases their interaction with Leishmania donovani promastigotes, by disruption of
lipid rafts [58]. On the other hand, an increase in membrane cholesterol content in
fibroblasts transformed with polyoma virus (PyF) has been shown to restore the
transformation-related loss of adhesivity in these cells [59]. Unpublished data from our
laboratory indicate that treatment with lipoprotein-cholesterol may enhance virulence
functions of E. histolytica like erythrophagocytosis and host cell cytolysis in a dose
dependant manner, presumably in the context of lipid rafts. Lujan and Diamond [60] have
previously indicated that E. histolytica may possess a de novo route of cholesterol
synthesis. However, subsequent studies have demonstrated the requirement of
lipoproteins rather than cholesterol, in the absence of which trophozoites cannot be
cultivated [61]. This important observation suggests that E. histolytica may not possess
functional machinery to synthesize cholesterol, and may rely on extracellular sources for
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the same. Thus, host cholesterol may be necessary for metabolism and survival of the
parasite.

Epidemiological data has demonstrated that lipid parameters might have an impact on the
outcome of parasitic infections. In a study conducted amongst patients of amoebiasis in
India, it was found that patients with non invasive amoebiasis (cyst passers) had lower
serum cholesterol levels in comparison to patients with invasive amoebiasis (amoebic
liver abscess) [62]. Interestingly, the most common site for manifestation of
extraintestinal amoebiasis is the liver, which is also the primary site for cholesterol
synthesis in the human body [63]. Laboratory evidence indicates that lipoprotein
enrichment can support E. histolytica growth in serum free media [64]. Since
trophozoites are unable to utilize free cholesterol in vitro, it is possible that in vivo,
cholesterol-enriched lipoprotein particles in the colonic lumen, tissue and/or serum act as
a source of cholesterol in successive stages of invasive disease [63]. In support of this
notion, it has been reported that a gradual decline in the ability of trophozoites to induce
hepatic abscess in hamsters occurs on prolonged growth in culture. More importantly,
this decrease in virulence is reversed on passage through hamster liver or through growth
in cholesterol-rich media [65]. Therefore, host cholesterol levels might regulate parasitic
virulence, but the exact mechanisms by which host lipids might influence pathogenecity
are still unclear. Taken together, these observations suggest that lipid rafts have a well
characterized role in cellular adhesion, and alterations in membrane cholesterol levels can
impact adhesivity of cells.
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IV. Implications and scope for the future
Great progress made in the past few years has advanced our understanding of the
determinants of parasitic invasion in E. histolytica. These investigations have revealed
fresh insight into the molecular mechanisms of disease, providing an impetus for vaccine
development and therapeutic targets. Specifically, the discovery of lipid rafts in E.
histolytica has been an important breakthrough [52]. The fact that the highly antigenic
Gal/GalNAc lectins, that are currently being used to develop new vaccines, localize to
lipid rafts, is a significant discovery. Therefore, an understanding of lipid raft function
and components is necessary to fully understanding E. histolytica virulence.

Despite the discovery of a specific receptor for E. histolytica-fibronectin interaction [45],
there is still uncertainty as to whether this receptor is lipid raft associated, or raftindependent. Since it shares greater than 96% homology with Igl, which is a raft-resident
glycoprotein, it is possible that the EhFNR may reside in rafts. There is also the
possibility that multiple receptors may be involved in adhesion to fibronectin, some of
which may be raft-associated. As for collagen, there is still considerable work that needs
to be done before a comprehensive understanding of the parasite’s interaction with
collagen can be attained. At the same time, it is essential that the mechanisms involved in
adhesion to the first line of immunological defense mucin, are explored further. Although
the Gal/GalNAc lectin is a well-established receptor for mucin, there is no concrete
evidence implicating the role of lipid rafts in this interaction. An additional question that
remains unanswered is whether there is an α-subunit homolog in E. histolytica integrin-
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like proteins. Although it is possible that functional, monomeric β subunits are expressed,
there is still insufficient evidence to rule out the presence of an α-subunit homolog.

This work is an investigation into the role of lipid rafts in adhesion to ECM components,
collagen and fibronectin. This study represents an attempt to answer some of the
questions outlined above, in order to enhance our understanding of molecular
mechanisms of amoebiasis. It is hoped that advancements in cell biology will enable the
prevention and eradication of this infectious agent.

V. Summary
Lipid rafts are heterogeneous, highly dynamic sterol- and sphingolipid-enriched domains
that spatially and temporally regulate physiological events. In E. histolytica, these
cholesterol-rich membranes play an important role in endocytosis, secretion and adhesion
of the parasite to host cells. To date, only one adhesion molecule, that is, the Gal/GalNAc
lectin, has been localized to rafts. In this study, we will investigate the role of lipid rafts
in adhesion of E. histolytica trophozoites to host ECM. More specifically, we will
examine the effects of cholesterol depletion as well as lipoprotein supplementation on
trophozoite adhesion to host ECM components, collagen and fibronectin. Further, we will
attempt to determine if the Gal/GalNAc lectin is the putative receptor within the rafts that
mediates adhesion to ECM. Thus, the specific aims for this study are:

1. To develop an assay to assess adhesion of E. histolytica trophozoites to ECM
components collagen and fibronectin.
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2. To determine if lipid rafts are involved in adhesion to collagen and fibronectin.
3. To determine whether the adhesion molecule Gal/GalNAc lectin, is the putative
receptor mediating trophozoite adhesion to ECM.

This is the first report that provides evidence suggesting involvement of lipid rafts in
adhesion of E. histolytica trophozoites to collagen and to fibronectin and the role of
Gal/GalNAc lectin in adhesion to collagen.
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CHAPTER 2
LIPID MICRODOMAINS ARE INVOLVED IN ADHESION OF
ENTAMOEBA HISTOLYTICA TROPHOZOITES TO
HOST EXTRACELLULAR MATRIX COMPONENTS.

I. Abstract
Entamoeba histolytica is a parasitic human protozoan that afflicts 50,000,000 people
worldwide annually. In the course of the parasite’s life cycle, motile trophozoites breach
the colonic mucosa, invade through the epithelial layer and extracellular matrix (ECM)
and occasionally disseminate through portal blood vessels to distant organs. Membrane
rafts are small heterogeneous, highly dynamic, sterol- and sphingolipid- enriched
domains whose functional significance entails compartmentalization of cellular processes
and regulation of cellular signaling. Recent studies reveal the physiological role of
membrane rafts in adhesion to host epithelium in E. histolytica. In the current study we
examined the role of lipid rafts in adhesion of trophozoites to host ECM components,
collagen and fibronectin. A high throughput fluorescence based assay was developed to
assess parasitic adhesion to commercial collagen type I- and fibronectin-coated microtiter
plates. Disruption of membrane rafts by treatment with a cholesterol extracting agent,
methyl-beta-cyclodextrin (MβCD), resulted in inhibition of adhesion to ECM.
Replenishment of cholesterol by treatment with a lipoprotein-cholesterol concentrate
(LCC) restored the inhibition of adhesion. Confocal microscopy, using fluorescent lipid
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analogs, revealed enrichment of lipids at the parasite-ECM interface. The galactose
inhibitable Gal/GalNAc lectin is a glycoprotein on E. histolytica that is a known resident
of lipid rafts and mediates adhesion to host cells. Adhesion to collagen was observed to
decline in the presence of galactose, suggesting a role for the Gal/GalNAc lectin as a
putative receptor mediating adhesion to collagen. On the other hand, adhesion to
fibronectin was not impaired by galactose, suggesting that the Gal/GalNAc lectin is not
involved in adhesion of E. histolytica to fibronectin. This study has offered new insight
into the molecular mechanisms of adhesion, which is important to the pathogenesis of
amoebiasis. Such insight may lead to the development of innovative therapeutic
modalities and vaccines.

II. Introduction
Entamoeba histolytica is a human intestinal pathogen that ranks second as a cause of
morbidity and mortality due to parasitic infections worldwide [1]. Transmitted by the
fecal-oral route, ingestion of the infective cyst form occurs via contaminated food and
water. In the pre-invasive form of the disease, motile trophozoites, resulting from
excystation in the small intestine or colon, interact with the mucin layer that forms the
body’s first line of defense. In the invasive stage of amoebiasis, E. histolytica
trophozoites breach the mucus secreting epithelium of the human colon and encounter the
submucosa, which is comprised of loose connective tissue, blood vessels and
extracellular matrix (ECM) components, including collagen and fibronectin. Destruction
of epithelium and the ECM that surrounds the epithelial cells produces flask shaped
ulcers [1]. The resultant manifestations, including diarrhea and dysentery, are major
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public health concerns in developing and underdeveloped countries. In some cases,
colonic invasion can result in dissemination of trophozoites to extra-intestinal sites like
liver, lungs and brain through the portal vascular system, resulting in amoebic abscess [1].
Thus, adhesion to ECM components and their subsequent degradation facilitates invasion
and is a critical step in the pathogenesis of amoebiasis.

Several lines of evidence suggest that adhesion of E. histolytica to ECM may be likened
to focal adhesions of higher eukaryotes [2, 3]. This interaction is also believed to alter
signal transduction pathways and enhance parasitic virulence [2, 4, 5]. For example,
exposure of E. histolytica trophozoites to collagen induces actin accumulation and
phosphorylation of tyrosine residues on the E. histolytica homolog of pp125FAK [3, 6, 7].
pp125FAK is a non receptor cytosolic focal adhesion kinase (FAK) that localizes to
adhesion plaques and is activated by tyrosine phosphorylation [6]. Exposure of E.
histolytica to collagen also stimulates pp125FAK association with paxillin and Src (pp60src),
which may result in increased DNA binding of the transcription factor AP-1 [7]. Collagen
also induces phosphorylation of p42MAPK, which may propagate a phosphorylation-based
signal from the plasma membrane to the nucleus [6]. In addition, exposure of
trophozoites to collagen has been shown to increase DNA binding of several other E.
histolytica transcription factors such as STAT1 and STAT3 [4]. This, in turn, may
regulate changes in gene expression. In support of this, collagen exposure results in
increased expression of an amoebapore and a cysteine protease, two secreted proteins
which aid in host tissue destruction [5]. Likewise, binding of E. histolytica trophozoites
to fibronectin induces phosphorylation of FAK, association of an integrin like receptor
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with paxillin, and activation of protein kinase A (PKA) [8, 9], a protein involved in Gprotein coupled receptor signaling. Additionally, exposure to fibronectin induces
reorganization of actin and its redistribution to the sites of adhesion [2, 10]. Since
exposure to ECM components may upregulate signaling events that modulate virulence, a
better understanding of adhesion to ECM may provide insight into pathogenic
mechanisms.

Recent evidence suggests that there exist highly-ordered cholesterol- and sphingolipidrich microdomains, termed lipid rafts, in the plasma membrane of E. histolytica. These
are thought to play an important role in endocytosis, secretion and adhesion of the
parasite to host cells [11]. In higher eukaryotes, lipid rafts serve as signaling platforms in
which integrins, as well as other adhesion/signaling molecules, may reside or accumulate
in a signal-dependent fashion [11-13]. The existence and physiological relevance of these
rafts in E. histolytica has been shown through a variety of methods, including
fluorescence microscopy, using fluorescent lipid analogs which preferentially intercalate
into ordered membrane domains, raft disruption using specific cholesterol-binding
reagents, and biochemical isolation and characterization of membrane microdomains [11].
That a previous study indicated that the galactose and N-acetyl-D-galactosamine
inhibitable lectin (Gal/GalNAc lectin), an adherence lectin of E. histolytica, is localized
to rafts, supports the role of such domains during adhesion to host components [11]. The
Gal/GalNAc lectin is composed of a 170 kDa transmembrane heavy chain subunit (Hgl)
linked via a disulphide bond to a light subunit (Lgl; 31-35 kDa); which is GPI-anchored.
These subunits are non-covalently associated with a 150 kDa intermediate subunit (Igl)
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[reviewed in 14]. The Gal/GalNAc lectin has been postulated to bind to galactose and Nacetylgalactosamine residues of host glycoconjugates on mucin, epithelial cells and
erythrocytes [15-17]. In light of these observations, and in light of the fact that ECM
components are glycosylated, it is conceivable that lipid raft-resident molecular
components, like the Gal/GalNAc lectin, may also be involved in adhesion to host ECM.

The present study provides insight into the involvement of lipid rafts in adhesion of E.
histolytica trophozoites to elements of the host ECM. Here we demonstrate that
disruption of rafts inhibits adhesion to host ECM, and that lipoprotein supplementation
enhances adhesion. Using fluorescence microscopy, we show that raft membranes
accumulate at the trophozoite-ECM interface. Treatment with galactose also inhibits
adhesion to collagen, which may implicate the Gal/GalNAc lectin in this important
adhesion event. However, adhesion to fibronectin appears to occur independent of the
Gal/GalNAc lectin, though adhesion to fibronectin may be partially mediated by lipid
rafts.

III. Materials and Methods
Strains and culture conditions
E. histolytica trophozoites, strain HM-1:IMSS, were cultured axenically in TYI-S-33
medium in screw-cap glass tubes at 37°C [18]. Log phase harvested trophozoites were
used for all experiments. Chinese hamster ovary (CHO) cells were cultured at 37°C in 25
cm2 angle-necked cell culture flasks in Dulbecco’s modified Eagle’s medium
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(Biowhittaker, Walkersville, MD) supplemented with fetal bovine serum (10% v/v), 1M
HEPES (Invitrogen, Carlsbad, CA), and penicillin-streptomycin (Invitrogen) (1% v/v).

Measurement of adhesion to CHO cells
CHO cells have been previously used as a model for host epithelium [19, 20]. To test the
effect of cholesterol on adhesion to host cells, we used a standard adhesion assay
described by Powell et al. [21]. CHO cells were grown to confluency in 96-well plates.
The CHO monolayer was then fixed with 4% paraformaldehyde to prevent cytolysis,
washed twice with PBS, incubated in 250 mM glycine to inactivate residual
paraformaldehyde activity and then washed twice with PBS. Log phase E. histolytica
trophozoites were iced for 8 minutes to dislodge them from glass, pelleted by
centrifugation (500 x g for 5 minutes) and then resuspended in prewarmed TYI-33 media.
Trophozoites were then dispensed in 15 ml conicals and labeled with 5 µg/ml Calcein
AM (Invitrogen), a green fluorescent vital stain, at 37°C for 60 minutes. Some of these
trophozoites were treated with the cholesterol-depleting agent methyl-β-cyclodextrin
(MβCD) (Sigma-Aldrich, St. Louis, MO), during the last 30 minutes of Calcein AM
staining. In all cases, MβCD was dissolved in TYI-33 media (TYI-S-33 media without
serum) to attain a final concentration of 15 mM. Untreated control cells, as well as raftdisrupted cells were then centrifuged (500 x g for 5 minutes) and re-suspended in media
with or without bovine lipoprotein-cholesterol concentrate (LCC) (MP Biomedicals,
Solon, OH) and incubated at 37°C for 15 minutes. LCC was used at a concentration that
provided 0.5 µg/ml cholesterol. 3 X 104 control cells as well as treated cells were then
seeded onto the CHO monolayer. Following incubation at 37°C for 30 minutes, non
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adherent cells were removed by gently washing the wells twice with warm phosphatebuffered saline (PBS).

The relative fluorescence, as a measure of adhesivity, was

assessed using a fluorescence plate reader (Model FLX800, BioTek Instruments,
Winooski, VT). The excitation and emission wavelengths used were 485 nm and 528 nm,
respectively.

Measurement of E. histolytica adhesion to ECM
A standard assay for measuring adhesion to host epithelial cells was adapted for
measuring adhesion to ECM [21]. Log phase trophozoites, labeled with Calcein AM, as
described above, were seeded onto commercial collagen type I- or fibronectin-coated 96well plates (BD Biosciences, Bedford, MA) at increasing concentrations, from 1 X 104 to
20 X 104 cells per well. Following incubation at 37°C for 15 minutes, unbound cells were
washed and the level of adhesion was measured by spectrofluorimetry. Alternatively, the
number of adherent cells was determined by counting 5 fields per well by examination at
a magnification of 40X on an Olympus CK2 inverted light microscope. The number of
cells to be seeded into the wells for subsequent experiments, as well as the incubation
time, was determined empirically by examining a range of cell concentrations and a range
of incubation times. To test the role of lipid rafts in adhesion to ECM, adhesion assays, as
described above were performed with cells that were treated with a range of
concentrations of MβCD, and/or 0.5 µg/ml LCC.
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Lipid raft staining
Trophozoites were allowed to adhere to glass (control), collagen type I- or fibronectincoated cover slips (BD Biosciences) in serum-free medium. Following incubation at
37°C for 15 minutes, the medium was aspirated and the non adherent cells were removed
by washing twice with warm PBS. The cells were fixed by treatment with 4% (v/v)
paraformaldehyde for 10 minutes at room temperature. After fixing, cells were washed
twice with PBS, and then incubated with the fluorescent lipid raft stain, 1,1'-dihexadecyl3,3,3',3'-tetramethylindocarbocyanine perchlorate (DiIC16) [22] (4.5 mM; Molecular
Probes, Eugene, OR), for 10 minutes. The cover slips were then washed twice with PBS,
mounted in PBS and observed using a Zeiss LSM 510 confocal microscope.

Galactose-mediated inhibition of amoebic adhesion to ECM
To test if the Gal/GalNAc lectin is involved in adhesion to ECM, Calcein AM stained
trophozoites were incubated on collagen type I- or fibronectin-coated plates in the
presence of a range of concentrations of D(+) Galactose (Sigma-Aldrich) from 10 mM to
100 mM. Galactose was dissolved in TYI-33 media to obtain the appropriate
concentration. As a control, adhesion was also tested in presence of 100 mM Mannose
(Sigma-Aldrich) [15, 16], which was also dissolved in TYI-33 media.

Statistical Analyses
All values represent the mean ± standard deviations [SD] of at least three trials. Statistical
analyses were performed using GraphPad Instat (version 3.05; IBM) with one-way
ANOVA with post-tests. P-values less than 0.05 were considered statistically significant
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and were denoted by a single asterisk (*). P-values less than 0.01 were considered highly
statistically significant and were denoted by two (**) asterisks. The mean inhibitory dose
(IC50) was calculated using the line of best fit generated by TableCurve2D version 5.01
(Systat).

IV. Results
Development of a high throughput adhesion assay for quantifying adhesion of
E. histolytica to collagen and fibronectin
In order to assess the role of lipid rafts in parasite-host ECM interaction, we developed a
high-throughput assay for quantifying this cellular function. To this end, we adapted a
standard adhesion assay used to measure adhesion of E. histolytica to host epithelial cells
[21]. Trophozoites were stained with Calcein AM, a membrane permeant compound that
is metabolized by intracellular esterases in live cells into a membrane impermeant
fluorescent cytoplasmic dye [23]. To determine if Calcein AM staining inhibits adhesion
to ECM, an equal number of Calcein AM-stained or unstained cells were added to the
wells of collagen type I- or fibronectin-coated microtiter plates. The number of adherent
cells was determined by counting 5 fields per well using a light microscope. It was
observed that there was no significant difference between the number of adherent cells
with or without treatment with Calcein AM (Fig. 2.1), suggesting that staining with
Calcein AM does not impact adhesivity of cells to ECM.

Calcein AM stained cells were then added, in increasing numbers, to successive wells of
the coated plates. After incubation for 15 minutes, non adherent cells were removed by
gentle washing. The level of adhesion was quantified by assessing fluorescence intensity
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of adherent cells using spectrofluorimetry. As cell number increased from 1 X 104 cells
per well to 5 X 104 cells per well, the relative fluorescence intensity increased linearly.
Beyond this concentration, a plateau was observed (Fig. 2.2).
Therefore 5 X 104 cells per well represents the maximum number of cells that can adhere
likely due to the limited surface area of a single microtiter well. To refine standard
adhesion curves, we repeated the adhesion assays using cell concentrations only in the
linear range of the initial graph, that is, 1 X 104 to 5 X 104 cells per well (Fig. 2.3). The
statistically significant linear increase in relative fluorescence within this range of cell
concentrations suggests that this assay authentically quantifies adhesion of E. histolytica
to ECM components. From these standard curves, we determined 2.5 X 104 cells per
well to be a median cell number which was used for all subsequent experiments. Using a
median cell number would allow us to observe both decreases and increases in adhesion
to ECM. In preliminary experiments, a range of incubation times, from 15 minutes to 2
hours were tested (data not shown). At the 15 minute time point, fluorescence intensity
increased maximally with increasing cell number and therefore this time point was used
for all further assays.
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Figure 2.1. Calcein AM does not inhibit adhesion of E. histolytica to ECM.
2.5 X 104 Calcein AM stained and unstained control cells were incubated in the wells of
(A) collagen- and (B) fibronectin-coated 96-well microtiter plates. Adherent cells were
counted by naked eye using a light microscope in 5 fields per well in triplicate. The level
of adhesion of Calcein AM stained cells was not significantly different from that of
unstained control cells. The results represent the mean ± standard deviation of three trials
for (A) collagen (P> 0.065) as well as (B) fibronectin (P> 0.5). Calcein AM does not
inhibit adhesion of E. histolytica to ECM.
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Figure 2.2. Adhesion of E. histolytica to ECM.
Calcein AM-stained E. histolytica cells were seeded in increasing numbers in the wells of
(A) collagen- and (B) fibronectin-coated 96-well microtiter plates. Relative fluorescence
increased linearly with increasing cell concentration from 1 X 104 to 5 X 104 cells per
well. Fluorescence intensity did not increase significantly at concentrations greater than 5
X 104 cells per well, suggesting that this concentration represents the maximum number
of cells that can adhere to a microtiter well surface. The values represent the mean from
triplicate wells in a single representative experiment.
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Figure 2.3. Standard adhesion curves for E. histolytica adhesion to ECM.
Calcein AM-stained E. histolytica cells were seeded in increasing numbers into wells of
(A)collagen- and (B)fibronectin-coated 96-well microtiter plates at concentrations from 1
X 104 to 5 X 104 cells per well. Relative fluorescence was measured by
spectrofluorimetry. Fluorescence intensity increases linearly with cell number. The data
represent the mean ± standard deviation of 3 trials for (A) collagen (R2=0.9884) and 4
trials for (B) fibronectin (R2=0.9868).
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Extracellular lipoprotein reverses MβCD-induced inhibition of E. histolytica adhesion to
host cells
Recent evidence suggests that E. histolytica trophozoites bind to host epithelial cells
through cholesterol- and sphingolipid-rich membrane microdomains known as lipid rafts.
The evidence includes the observation that disruption of these microdomains, using
MβCD, inhibits adhesion to host epithelial cells [11]. MβCD is a surface-acting cyclic
heptasaccharide

that

selectively

extracts

membrane

cholesterol

by

reversibly

encapsulating it in a central hydrophobic core [24, 25]. To further explore the role of
cholesterol-rich membrane in adhesion to host cells and to explore the specificity of
MβCD for future experiments, we tested the effect of cholesterol addition on adhesion of
trophozoites to host cells. Since it has been reported that E. histolytica cells cannot use
free cholesterol [26], we treated trophozoites with lipoprotein-cholesterol concentrate
(LCC) and measured their ability to adhere to host epithelial cells. Adhesion to host cells
was significantly increased in the presence of LCC. This further supports the involvement
of cholesterol in adhesion to host epithelium and suggests that this concentrate may be
useful to test the role of cholesterol-rich membrane in adhesion to other surfaces.

We then treated trophozoites with MβCD alone or MβCD followed by LCC. Consistent
with previous results [11], MβCD significantly reduced adhesion to host cells by 47.5%
(Fig. 2.4). Interestingly, treatment with LCC restored MβCD-induced adhesion to near
normal levels. This observation supports the authenticity of the mode of action of MβCD
as a cholesterol-sequestering agent. Therefore, MβCD may also be a useful agent to test
the role of cholesterol-rich membrane in adhesion to other surfaces. The concentration of
LCC used provided 0.5 µg/ml cholesterol. Since this concentration restored MβCD-
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induced inhibition of adhesion to near normal levels, this concentration was used in all
subsequent experiments. For both treated and untreated cells, more than 86% of cells
remained viable during the experiments, as determined by trypan blue exclusion (data not
shown). This suggests that observed changes in adhesion were a physiological effect of
cholesterol depletion, and not a result of decreased viability of the cells.
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Figure 2.4. Restoration of MβCD-induced inhibition of adhesion on host epithelial cells
by LCC treatment.
Adhesion of Calcein AM-stained cells pretreated with lipoprotein-cholesterol (LCC; 0.5
µg/ml cholesterol), Methyl-β-cyclodextrin (MβCD; 15mM), or MβCD treatment
followed by treatment with lipoprotein-cholesterol (MβCD + LCC) was quantified by
spectrofluorimetry. The data are presented as a percentage of adhesion of untreated
control cells which was arbitrarily set to 100%. The level of adhesion after lipoproteincholesterol treatment or after MβCD treatment was significantly different from control
(n=3,**P<0.01). The level of adhesion of cells treated with MβCD followed by LCC was
not significantly different from control. Treatment with LCC enhances adhesion to host
cells and can reverse MβCD-induced inhibition of adhesion.

40

MβCD decreases adhesion to ECM in a dose-dependant fashion
To determine if lipid rafts are involved in adhesion to host ECM components, collagen
and fibronectin, we assessed adhesion of trophozoites to ECM-coated plates after
biochemical disruption of lipid rafts using MβCD as described above and previously [11].
Adhesion to collagen and fibronectin decreased, in a dose-dependant fashion, after
treatment with MβCD (Fig. 2.5). The mean inhibitory concentration (IC50) of MβCD for
collagen was determined to be 27 mM. It is noteworthy that while, at a concentration of
15 mM, MβCD was able to inhibit adhesion to collagen by 43.66%, it was only able to
inhibit adhesion to fibronectin by 27.17%. Although this was a statistically significant
decrease (P<0.05), lipid rafts play a lesser role in adhesion to fibronectin than to collagen.

Extracellular lipoprotein reverses MβCD-induced inhibition of adhesion to ECM
In order to assess the specific effect of membrane cholesterol level on adhesion to ECM,
control cells and cholesterol depleted cells were suspended in media supplemented with
or without LCC. Subsequently, their ability to adhere to host ECM was determined using
the fluorescence-based assay described above. Treatment with LCC alone increased
adhesion to both host substrates (Fig. 2.6, 2.7). MβCD treatment inhibited adhesion to
collagen by 60%. While adhesion to fibronectin was decreased by 44% after raft
disruption, this decline was not found to be statistically significant. This supports our
previous observation suggesting lipid rafts play a lesser role in adhesion to fibronectin,
and that raft-independent mechanisms must also participate in this process. Treatment of
raft-disrupted cells with LCC restored adhesion to both collagen and fibronectin (Fig 2.6,
2.7). This suggests that cholesterol-rich membrane is important in adhesion to host ECM

41

and that MβCD-induced inhibition of adhesion is, in fact, the result of loss of lipid. We
cannot rule out the possibility that another component of LCC enhanced adhesion may
have over-ridden MβCD induced inhibition of adhesion. However, others have used
repletion of cholesterol after raft disruption as a successful approach to demonstrate the
role of lipid rafts in various physiological processes [27-29]. Overall, our observations
support the notion that cholesterol-rich membrane may be involved in adhesion to host
ECM.
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Figure 2.5. MβCD-mediated inhibition of adhesion to collagen and fibronectin.
Calcein AM-treated E. histolytica trophozoites were treated with a range of
concentrations of MβCD prior to incubation on (A) collagen and (B) fibronectin surfaces.
The data are presented as a percentage of adhesion of cells not treated with MβCD (0 mM)
which was arbitrarily set to 100%. MßCD inhibits adhesion of trophozoites to both ECM
components in a dose-dependant fashion (n=3). P-values less than 0.05 are considered
statistically significant and are denoted by a single asterisk (*). P-values less than 0.01
are considered highly statistically significant and are denoted by two (**) asterisks.
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Figure 2.6. Raft disruption and exposure to lipoprotein affect adhesion to collagen.
Adhesion of Calcein AM-stained cells pretreated with lipoprotein-cholesterol concentrate
(LCC; 0.5 µg/ml cholesterol), methyl-β-cyclodextrin (MβCD; 15mM), or MβCD
treatment followed by treatment with LCC (MβCD + LCC) was quantified by
spectrofluorimetry. The data are presented as percentage of adhesion of untreated control
cells which was arbitrarily set to 100%. The level of adhesion after LCC treatment or
after MβCD treatment was significantly different from control (n=3, **P<0.01). The
level of adhesion for cells treated with MβCD followed by LCC was not significantly
different from control. Treatment with LCC can reverse MβCD-induced inhibition of
adhesion to collagen.
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Figure 2.7. Raft disruption and exposure to lipoprotein affect adhesion to fibronectin.
Adhesion of Calcein AM-stained cells pretreated with lipoprotein-cholesterol concentrate
(LCC; 0.5 µg/ml cholesterol), methyl-β-cyclodextrin (MβCD; 15mM), or MβCD
treatment followed by treatment with LCC (MβCD + LCC) was quantified by
spectrofluorimetry. The data are presented as percentage of adhesion of untreated control
cells which was arbitrarily set to 100%.The level of adhesion after treatment with LCC
was significantly different from control (n=4, **P<0.01). The level of adhesion after
treatment with MβCD or MβCD + LCC was not significantly different from that of
control (n=4, P>0.05). Treatment with LCC can reverse MβCD-induced inhibition of
adhesion to fibronectin.
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Raft microdomains accumulate at the site of parasite–ECM contact
Since raft-disrupting agents inhibit adhesion, and since lipoprotein enhances adhesion to
ECM, it is conceivable that rafts might accumulate at the parasite-ECM interface. To
determine if raft microdomains enrich at these contact sites, we allowed E. histolytica
trophozoites to adhere to ECM coated cover slips and stained these cells with the
fluorescent lipid raft stain, DiIC16 [22]. Raft microdomains were found to accumulate at
the parasite-ECM interface, thereby supporting a role for these microdomains in parasiteECM interactions (Fig. 2.8, 2.9). In contrast, DiIC16-stained domains were not
particularly enriched at the contact site of trophozoites with glass. Rather, in these control
cells, DiIC16-stained domains were observed to be distributed uniformly throughout the
plasma membrane of the cell (Fig. 2.10). This supports the authenticity of our
microscopic observations of trophozoites on ECM surfaces.
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Figure 2.8. Lipid raft enrichment at parasite-collagen interface.
Fluorescence microscopy images of DiIC16-stained cells adhering to collagen
demonstrate the adherent surface of 2 cells (A, G) in x-y plane, enriched in lipid rafts.
Panels D, J represent the non adherent surface of the cell. M, N are 3 dimensional
reconstructions viewed in x-z plane indicating the accumulation of lipids at the interface
(depicted by arrow). B, E, H and K represent differential interference contrast (DIC)
images while C, F, I and L represent the merged images respectively. Scale bars represent
10 µm.
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Figure 2.9. Lipid raft enrichment at parasite-fibronectin interface.
Fluorescence microscopy images of DiIC16 stained cells adhering to fibronectin
demonstrate the adherent surface of 2 cells (A, G), in x-y plane, enriched in lipid rafts.
Panels D, J represent the non adherent surface of the cell. M, N are 3 dimensional
reconstructions viewed in x-z plane indicating the accumulation of lipids at the interface
(depicted by arrow). B, E, H and K represent differential interference contrast (DIC)
images while C, F, I and L represent the merged images respectively. Scale bars represent
10 µm.
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Figure 2.10. Lipid rafts do not enrich at the interface of glass.
Fluorescence microscopy images of DiIC16 stained cells adhering to glass demonstrate the
adherent surface of 2 cells (A, G), in x-y plane. Panels D, J represent the non adherent
surface of the cell. M, N are 3 dimensional reconstructions viewed in x-z plane indicating
the presence of DiIC16-staining domains throughout the cell membrane. Arrow depicts
parasite-ECM interface. B, E, H and K represent differential interference contrast (DIC)
images while C, F, I and L represent the merged images respectively. Scale bars represent
10 µm.
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The Gal/GalNAc lectin is involved in adhesion to collagen, but not to fibronectin
Since lipid rafts are involved in adhesion of the parasite to ECM, it is conceivable that the
receptors for collagen and fibronectin reside within lipid rafts. To date, only one receptor
has been demonstrated to reside in rafts, that is, the Gal/GalNAc lectin [11]. It has been
previously demonstrated that the Gal/GalNAc lectin is involved in adhesion of E.
histolytica to host glycoconjugates [15, 16]. To determine if the Gal/GalNAc lectin
regulates adhesion to collagen and fibronectin, we quantified trophozoite adhesion to
ECM-coated plates in the presence of a range of concentrations of galactose. As a control,
adhesion was tested in the presence of 100 mM mannose, which has been shown to exert
a non inhibitory effect on adhesion to host cell glycoconjugates [15, 16]. Our results
indicated that galactose significantly decreases adhesion to collagen in a dose- dependant
fashion, while mannose exerts no significant effect on adhesion (Fig. 2.11 A). This
suggests that the Gal/GalNAc lectin may be a putative receptor within the lipid rafts that
is involved in adhesion of E. histolytica to collagen. The mean inhibitory concentration
(IC50) for collagen was determined to be 30 mM. However, galactose was found to exert
no significant inhibitory effect on adhesion of trophozoites to fibronectin (Fig. 2.11 B),
suggesting that receptors other than the Gal/GalNAc lectin may be involved in adhesion
to this substrate. This receptor or receptors may reside in raft or non-raft regions of the
cell.
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Figure 2.11. Galactose inhibits adhesion to collagen but not to fibronectin.
Calcein AM treated cells were incubated onto (A) collagen- and (B) fibronectin-coated
96 well plates in the presence of a range of concentrations of galactose (10-100 mM) or
100 mM mannose. After washing non adherent cells, adhesion was quantified by
spectrofluorimetry. The data are expressed as a percentage of adhesion of untreated
control cells which was arbitrarily set to 100%. The data represent mean ± standard
deviation of 3 trials for collagen and 4 trials for fibronectin. Galactose inhibits adhesion
to collagen in a dose dependant fashion. Galactose does not significantly inhibit adhesion
to fibronectin. Mannose exerts no significant effect on adhesion to either ECM
component (P > 0.05). P-values less than 0.01 are considered highly statistically
significant and were denoted by two (**) asterisks.
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V. Discussion
A key step in the pathogenesis of invasive amoebiasis is incursion of E. histolytica into
the lamina propria, which brings trophozoites in contact with extracellular matrix (ECM)
[30]. Since exposure to ECM components may upregulate signaling events as described
previously, an understanding of the molecular mechanisms of adhesion to ECM may
provide insight into disease pathogenesis. In this study, we have investigated the role of
lipid rafts in the interaction of E. histolytica with ECM elements, collagen and fibronectin.
We observed a dose-dependant decrease in adhesion of trophozoites to collagen and a
lesser decrease in adhesion to fibronectin, as a consequence of raft disruption. Our results
indicated that supplementation with cholesterol by treatment with lipoprotein-cholesterol
concentrate (LCC) leads to enhanced adhesion to ECM. LCC treatment also rescues the
decline in adhesion observed for raft disrupted cells. Together, these data suggest that
cholesterol-rich membrane participates in adhesion to collagen, and to a lesser extent,
fibronectin. In support of this, using fluorescence microscopy, we have observed the
enrichment of lipid rafts at the parasite-ECM interface. Finally, the Gal/GalNAc lectin, a
resident of lipid rafts, may be a putative receptor for adhesion to collagen, but is unlikely
to be involved in adhesion to fibronectin.

Membrane rafts are defined as highly dynamic sterol- and sphingolipid-enriched domains
that compartmentalize cellular processes [31]. The physiological role of lipid rafts in
cellular adhesion has been the subject of numerous studies, including a study in E.
histolytica [11]. Previous research also suggests a positive correlation between the
membrane cholesterol levels and adhesivity of cells. In fibroblasts transformed with
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polyoma virus (PyF), an increase in membrane cholesterol content was shown to restore
the transformation related loss of adhesivity [32]. Huang et al. [33] recently demonstrated
that disruption of lipid rafts in human cancer cell lines inhibits cellular adhesion to
fibronectin, collagen and laminin, thereby affecting a crucial step in tumor invasion and
metastasis. In a murine system, detergent resistant fractions were found to be associated
with brain-derived tenascin glycoproteins of the ECM [34], supporting the notion that the
interaction of cells with ECM components might be raft-mediated. We present similar
evidence suggesting, for the first time, a role of lipid rafts in adhesion of E. histolytica to
host collagen and to a lesser extent, fibronectin.

Epidemiological data has demonstrated that patients with non invasive amoebiasis (cyst
passers) have lower cholesterol levels in comparison to patients with invasive amoebiasis
(amoebic liver abscess) [35]. A region around Hue΄ City in central Vietnam has reported
an extraordinarily high number of male patients with amoebic liver abscess. [36]. It is
remarkable that according to the WHO Global Infobase [37], the mean serum cholesterol
level in males in Vietnam (5.4 mM/L total cholesterol) is higher than that in males in
other areas where amoebiasis is endemic, like India (5.1 mM/L) and Mexico (4.8 mM/L).
It is not our intention to oversimplify the contribution of cholesterol to the outcome of
amoebiasis, and we realize that confounding factors such as differences in nutrition,
general poor health, and other co-morbid conditions may also contribute to the
pathogenesis of disease. However, it is still interesting that the most common site for
manifestation of extraintestinal amoebiasis is the liver, which is also the primary site for
cholesterol synthesis in the human body [38]. Laboratory evidence indicates that
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lipoprotein enrichment can support E. histolytica growth in serum free media [39]. Since
trophozoites are unable to utilize free cholesterol in vitro [26], it is possible that in vivo,
cholesterol-enriched lipoprotein particles in the colonic lumen, tissue and/or serum act as
a source of cholesterol in successive stages of invasive disease [38]. In support of this
notion, it has been reported that a gradual decline in the ability of trophozoites to induce
hepatic abscess in hamsters occurs on prolonged growth in culture. More importantly,
this decrease in virulence is reversed on passage through hamster liver or through growth
in cholesterol-rich media [40]. Also, unpublished data from our laboratory indicate that
treatment with lipoprotein-cholesterol may enhance other virulence functions of E.
histolytica like erythrophagocytosis and host cell cytolysis in a dose dependant manner.
Therefore, host cholesterol levels might regulate parasitic virulence, but the exact
mechanisms by which host lipids might influence pathogenecity must still be investigated.
Indeed, enhanced adhesion, as a result of cholesterol exposure, as shown in this study,
may be a contributory factor.

Diabetes has also been postulated to be a risk factor for amoebiasis [41]. In a
retrospective study conducted in Taiwan, patients with diabetes mellitus were found to
have a greater incidence of severe amoebic liver abscess [42]. Likewise, amongst patients
of amoebiasis in Mexico, a frequent disease association between incidence of diabetes
and the development of fulminant amoebic colitis was established [43]. The latter is a
rare complication of amoebiasis, carrying high morbidity and mortality [44]. The role of
diabetes as a prognostic factor in amoebiasis has been explained by the compromised
immunity in diabetic patients, and also due to the microangiopathy that occurs in the
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intestinal vasculature in diabetics [41]. Given the well established association between
hyperglycemia and hypercholesterolemia, we hypothesize that high cholesterol levels
may be an additional mechanism which may contribute to a worse disease outcome in
diabetic patients with amoebiasis.

Curiously, raft disruption is unable to abolish adhesion completely.

For instance, at a

dose of 15 mM MβCD, there was only a 44% observed decline in adhesion of
trophozoites to fibronectin. An explanation for this might lie in the proposed hypothetical
model for organization of sphingolipids, cholesterol and GPI-anchored proteins based on
their behavior after treatment with MβCD [45]. According to this model, a small fraction
of cholesterol, in the core of sphingolipid-rich domains, is resistant to extraction by
MβCD. Pucadyil et al. [46] investigated the membrane cholesterol content of
macrophages after treatment with 10 mM MβCD and found only a 40% decline in
cholesterol at this treatment concentration. Thus, it is possible that lipid rafts are not
completely impaired by MβCD treatment, which could account for the residual adhesion.
On the other hand, incomplete inhibition of adhesion may suggest that raft independent
mechanisms may also be involved in adhesion to ECM.

Despite a lesser decline in adhesion of raft-disrupted trophozoites to fibronectin than to
collagen, it is noteworthy that LCC prominently enhances adhesion to this ECM
component. Thus, there exists a possibility that at least one receptor for adhesion to
fibronectin may not rely on rafts, but lipid rafts still play a partial role in interaction with
fibronectin. An interesting observation has been the restoration of adhesion to near-
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normal levels in raft disrupted cells upon LCC treatment. This supports the notion that
the defect in adhesion in raft-disrupted cells is due to a reversible loss of lipids. Again,
we cannot disregard the possibility that LCC enhances adhesion by a mechanism
exclusive of lipid rafts, and the reversion of cellular adhesion is merely an additive
outcome of two independent mechanisms.

To visualize the cellular interface of the parasite with ECM and to gain a better
understanding of cell-ECM interactions, a variety of approaches have been utilized in the
past. One of these strategies included the use of three-dimensional ECM matrices that
enabled observation of cells such as neutrophils [47] and T lymphocytes [48] interacting
with ECM. In E. histolytica, adhesion to collagen and fibronectin is believed to simulate
formation of focal adhesions similar to those in higher eukaryotes [2, 3]. Recently, a
novel strategy, employing the use of atomic force microscopy, has revealed formation of
adhesion plaques when E. histolytica trophozoites adhere to fibronectin-coated cover
slips [49]. Previously, fluorescent lipid raft stain, DiIC16, was used to demonstrate the
existence of raft domains in the plasma membrane of E. histolytica [11], and we utilized a
similar approach to study the parasite’s adhesion to ECM. We observed an enrichment of
lipid raft stain at the parasite-ECM interface on collagen- or fibronectin-coated cover
slips using fluorescence microscopy. In contrast, cells adherent to glass did not exhibit
accumulation of rafts at the site of adhesion, and DiIC16-stained domains appeared to be
distributed throughout the cell membrane in these control cells. We believe that these
findings reflect the specific involvement of lipid rafts in interaction with ECM. Since
adhesion, invasion and subsequent degradation of ECM is the natural sequence of events
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in the pathogenesis of amoebiasis, it is conceivable that trophozoites would adhere and
subsequently attempt to embed themselves in the thin ECM layer on the pre-coated cover
slip. For each of the surfaces, the optical parameters were adjusted to ensure that staining
at the non adherent surface of the cell was absent. Thus, a quantitative comparison of
DiIC16-stained domains at the interface with collagen and fibronectin cannot be made. A
suggested improvement over this technique would be to maintain uniform laser
parameters while imaging cells adherent to different ECM surfaces. It would also be
interesting to observe migration patterns of E. histolytica through 3-D ECM matrices in
vitro, since this might allow for quantification of ECM degradation.

The molecular components within the raft that may be involved in adhesion are still
under investigation. The most commonly implicated protein in adhesion mechanisms is
the Gal/GalNAc lectin. It has been established that the Gal/GalNAc lectin binds to
galactose and N-acetylgalactosamine residues on host glycoconjugates and thus mediates
adherence and cytotoxicity of the parasite [15, 16, 50, 51]. The heavy subunit of this
lectin, the Hgl, contains a carbohydrate recognition domain [14] and monoclonal
antibodies against this subunit of lectin inhibit adhesion to host cells [52]. An important
discovery has been that of enrichment of the Gal/GalNAc lectin heavy subunit in the
detergent resistant membrane fraction, that is, the lipid raft [11]. In this study, we
observed a dose-dependant, galactose-mediated, inhibition of adhesion to collagen. A
control sugar, mannose did not have a significant effect on adhesion. This finding
suggests the involvement of Gal/GalNAc lectin, perhaps as a raft-resident protein, in
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adhesion to collagen. Since galactose did not significantly inhibit adhesion to fibronectin,
interaction with fibronectin does not involve the Gal/GalNAc lectin.

Numerous studies have indicated that integrins are responsible, in part, for mammalian
cell-ECM interactions [53]. Previous reports demonstrate the existence of an integrin-like
molecule in E. histolytica that mediates interactions with fibronectin as well as collagen
[54]. It is proposed that a 140 kDa β1 integrin-like molecule (EhFNR), upon adhesion to
fibronectin, assembles a multimolecular complex that activates signaling pathways within
the cell [8]. Interestingly, it has also been demonstrated recently that the EhFNR bears
greater than 96% sequence homology with the C terminal domain of the intermediate
chain of the Gal/GalNAc lectin (Igl) [54]. Another subunit of the Gal/GalNAc lectin, the
Hgl also exhibits homology to β2 and β7 mammalian integrins in its C terminus [20]. The
exact relationship between integrins and lipid raft, and more specifically, the EhFNR, the
Gal/GalNAc lectin and lipid raft is still unclear. Yet, this study has offered evidence
implicating lipid rafts in adhesion to both ECM components, and has substantiated the
involvement of Gal/GalNAc lectin in adhesion to collagen. Future studies may generate a
more comprehensive picture investigating hitherto unknown receptors, both within, and
outside the rafts, that interact with ECM and aid in invasion of the host.
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